tiprankstipranks
Trending News
More News >
Hypha Labs, Inc. (FUNI)
:FUNI
US Market
Advertisement

Hypha Labs (FUNI) Price & Analysis

Compare
16 Followers

FUNI Stock Chart & Stats

$0.02
>-$0.01(-17.23%)
At close: 4:00 PM EST
$0.02
>-$0.01(-17.23%)

FUNI FAQ

What was Hypha Labs, Inc.’s price range in the past 12 months?
Hypha Labs, Inc. lowest stock price was <$0.01 and its highest was $0.04 in the past 12 months.
    What is Hypha Labs, Inc.’s market cap?
    Hypha Labs, Inc.’s market cap is $3.92M.
      When is Hypha Labs, Inc.’s upcoming earnings report date?
      Hypha Labs, Inc.’s upcoming earnings report date is Feb 18, 2025 which is 260 days ago.
        How were Hypha Labs, Inc.’s earnings last quarter?
        Currently, no data Available
        Is Hypha Labs, Inc. overvalued?
        According to Wall Street analysts Hypha Labs, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Hypha Labs, Inc. pay dividends?
          Hypha Labs, Inc. does not currently pay dividends.
          What is Hypha Labs, Inc.’s EPS estimate?
          Hypha Labs, Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Hypha Labs, Inc. have?
          Hypha Labs, Inc. has 145,121,830 shares outstanding.
            What happened to Hypha Labs, Inc.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Hypha Labs, Inc.?
            Currently, no hedge funds are holding shares in FUNI

            Company Description

            Hypha Labs, Inc.

            DigiPath, Inc. engages in the provision of cannabis testing, education, training, and news coverage. It operates through the Digipath Labs and GroSciences business units. The Digipath Labs business unit focuses on testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures. The GroSciences business unit plans to develop and license specific formulations to other producers and product makers in the industry. The company was founded by Todd Denkin on October 5, 2010 and is headquartered in Las Vegas, NV.
            Similar Stocks
            Company
            Price & Change
            Follow
            NovaBay Pharma
            Aethlon Medical
            Enveric Biosciences
            Evaxion Biotech
            SciSparc Ltd.

            Ownership Overview

            5.17%94.83%
            ― Other Institutional Investors
            94.83% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis